213 related articles for article (PubMed ID: 8114864)
21. Fatty acid oxidation disorders: maternal health and neonatal outcomes.
Rector RS; Ibdah JA
Semin Fetal Neonatal Med; 2010 Jun; 15(3):122-8. PubMed ID: 19926542
[TBL] [Abstract][Full Text] [Related]
22. [Hepatic mitochondrial fatty acid oxidation disorders].
Matsubara Y
Ryoikibetsu Shokogun Shirizu; 1995; (8):312-6. PubMed ID: 8581639
[No Abstract] [Full Text] [Related]
23. [Mitochondrial beta-oxidation defects: overview].
Yamaguchi S
Ryoikibetsu Shokogun Shirizu; 2001; (36):60-4. PubMed ID: 11596451
[No Abstract] [Full Text] [Related]
24. Alterations in energy metabolism in cardiomyopathies.
Taha M; Lopaschuk GD
Ann Med; 2007; 39(8):594-607. PubMed ID: 17934906
[TBL] [Abstract][Full Text] [Related]
25. Cardiomyopathies.
Olsen EG
Cardiovasc Clin; 1972; 4(2):239-61. PubMed ID: 4564385
[No Abstract] [Full Text] [Related]
26. Implications of impaired ketogenesis in fatty acid oxidation disorders.
Olpin SE
Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):293-308. PubMed ID: 14769488
[TBL] [Abstract][Full Text] [Related]
27. A review of fatty acid oxidation disorder mouse models.
Babcock SJ; Houten SM; Gillingham MB
Mol Genet Metab; 2024 May; 142(1):108351. PubMed ID: 38430613
[TBL] [Abstract][Full Text] [Related]
28. Review: Mitochondrial medicine--cardiomyopathy caused by defective oxidative phosphorylation.
Fosslien E
Ann Clin Lab Sci; 2003; 33(4):371-95. PubMed ID: 14584751
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of the pyruvate dehydrogenase complex and of mitochondrial fatty acid oxidation.
Bindoff LA; Birch-Machin MA; Jackson S; Singh Kler R; Bartlett K; Turnbull DM
Rev Neurol (Paris); 1991; 147(6-7):526-31. PubMed ID: 1962058
[TBL] [Abstract][Full Text] [Related]
30. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
Pollitt RJ
Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
[TBL] [Abstract][Full Text] [Related]
31. Inherited disorders of mitochondrial fatty acid oxidation: a new responsibility for the neonatologist.
Roe CR
Semin Neonatol; 2002 Feb; 7(1):37-47. PubMed ID: 12069537
[TBL] [Abstract][Full Text] [Related]
32. Update on mitochondrial fatty acid oxidation disorders.
Spiekerkoetter U; Mayatepek E
J Inherit Metab Dis; 2010 Oct; 33(5):467-8. PubMed ID: 20842433
[No Abstract] [Full Text] [Related]
33. Functions and dysfunctions of peroxisomes in fatty acid alpha- and beta-oxidation. New insights.
Wanders RJ
Adv Exp Med Biol; 1999; 466():283-99. PubMed ID: 10709655
[No Abstract] [Full Text] [Related]
34. Dicarboxylic acids and the lipid metabolism.
Mortensen PB
Dan Med Bull; 1984 Apr; 31(2):121-45. PubMed ID: 6426867
[No Abstract] [Full Text] [Related]
35. [The effect of ketalar on fatty acid metabolism in the myocardium].
Abidova SS; Ovchinnikov IV; Gimmel'farb GN
Eksp Klin Farmakol; 1994; 57(6):42-4. PubMed ID: 7756961
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
[TBL] [Abstract][Full Text] [Related]
37. Carnitine and the twins.
Bressler R
N Engl J Med; 1970 Mar; 282(13):745-6. PubMed ID: 5416207
[No Abstract] [Full Text] [Related]
38. The enzymes of mitochondrial fatty acid oxidation.
Bennett MJ
Clin Chim Acta; 1994 May; 226(2):211-24. PubMed ID: 7923814
[TBL] [Abstract][Full Text] [Related]
39. Variation in protein structure and inborn errors in metabolism.
Poole AE
Dent Clin North Am; 1975 Jan; 19(1):47-62. PubMed ID: 803265
[No Abstract] [Full Text] [Related]
40. [The action of anaprilin and ketamine on fatty acid metabolism in the myocardium].
Ovchinnikov IV; Gimmel'farb GN; Abidova SS
Farmakol Toksikol; 1989; 52(1):37-40. PubMed ID: 2707417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
